Jinming Di,M.D, Ph.D
Titles
Associate Professor of Surgery
Associate Chief Physician
Master's Supervisor
Committee members of laser society in Guangdong province Urological Association
Committee members of Sexual Medicine Association in Guangdong Urological and Reproductive Association
Research Interests
Basic study on prostate cancer, including
-The molecular mechanism of metastasis of prostate cance
- Diagnosis and treatment of prostate cancer
Clinical research, including
-Urological tumor
-Complicated open surgery
-Endourology
Education and Experience
Training
Medical school of Bengbu medical school in Anhui province(1988-1993)
lMD, School of Medicine, Shanghai Jiaotong University (1996-1999)
PhD, the Third Affiliated hospital of Sun Yat-sen University (2006-2009)
Residency
the Affiliated hospital of Bengbu medical school in Anhui province (1993-1996)
Certifications
Attending Doctor of urinary surgery(1999-2005)
Associate Professor of urinary surgery(2006-)
Master's Supervisor(2016)
Honors and Awards
None
Publications
1.Cyclooxygenase-2 expression is associated with vascular endothelial growth factor-C and lymph node metastases in human prostate cancer. Arch Med Res, 2009;40(4):268-275. Epub 2009 Jun 4.
2.Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells. Cancer Genet Cytogenet, 2009;192(2):60-67.
3.Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells. Mol Biol Rep, 2010;37(4):1849-55. Epub 2009 Jul 19.
4.Gao X, Pang J, Li LY (co-first author), Liu WP, Di JM, Sun QP, Fang YQ, Liu XP, Pu XY, He D, Li MT, Su ZL, Li BY. Expression profiling identifies new function of collapsin response mediator protein 4 as a metastasis-suppressor in prostate cancer. Oncogene. 2010 Aug 12;29(32):4555-66. Epub 2010 Jun 14. (IF: 7.357)
5.Unclamped nephron-sparing surgery with preoperative selective arterial embolization for the management of bilateral giant renal angiomyolipomas. Clin Genitourin Cancer, 2014 Jun;12(3):e111-4. doi: 10.1016/j.clgc.2013.12.006. Epub 2014 Jan 2. [Epub ahead of print]. (IF: 1.429)
6.You-Qiu Xue, Jin-Ming Di, Yun Luo, ke-Jun Cheng, Xing Wei, and Zhi Shi. Resveratrol Oligomers for the Prevention and Treatment of Cancers. Oxidative Medicine and Cellular Longevity, 2014;2014:765832. doi: 10.1155/2014/765832. Epub 2014 Mar 23. (IF: 3.393)
7.Wang T, Xie ZP, Huang ZS, Li H, Wei AY, Di JM, Xiao HJ, Zhang ZG, Cai LH, Tao X, Qi T, Chen DL, Chen J. Total triterpenoids from Ganoderma Lucidum suppresses prostate cancer cell growth by inducing growth arrest and apoptosis. J Huazhong Univ Sci Technolog Med Sci. 2015 Oct;35(5):736-41. doi: 10.1007/s11596-015-1499-x. Epub 2015 Oct 22.
8.Luo Y, Wu JY, Qiu JG (co-first author), Zhang WJ, Mei XL, Shi Z, Di JM.Regulation of migration and invasion by TLR9 signaling network in prostate cancer. Oncotarget, 2015, 6(26):22564-22574. (IF: 6.636)
9.Luo Y, Wu JY, HOU GL, Lu MH, Shi Z, Di JM. ODAM is a predictor for biomedical recurrence and inhibits the migration and invasion of prostate cancer. Am J Transl Res, 2016, 8(2):670-679.
Contact
Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University,
600W Tianhe Road, Guangzhou 510630, China.
Tel. +86 20 85252175;
Fax: +86 20 85252678.
